Tuberculosis News and Research

Latest Tuberculosis News and Research

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

TB urine test developed by Indian researchers offers quicker, less invasive diagnosis

"The Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, collaborated with the National University of Singapore to develop" a urine test that "offers a less invasive diagnostic method for" tuberculosis (TB), SciDev reports.

25 Aug 2011

Global Fund to resume suspended grants to China

The Global Fund to Fight AIDS, Tuberculosis and Malaria, which "froze disbursements of its AIDS grant to China in November and all other grants in May over suspected misuse of the money and the government's reluctance to involve community groups, ... said Tuesday that it was lifting the freeze on financing to ensure that AIDS work in China continued while it worked with government officials, representatives from United Nations agencies and private groups to resolve the dispute," the Associated Press reports.

25 Aug 2011

A pain-free way of tackling dental decay

Researchers at the University of Leeds have discovered a pain-free way of tackling dental decay that reverses the damage of acid attack and re-builds teeth as new.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

Fla., CMS discuss Medicaid managed care options; Calif. may shrink healthy families enrollment

A Florida proposal to shift nearly all of its 3 million Medicaid patients into managed care is emerging as a national test case for how lenient CMS will be as cash-strapped states look for savings in their most expensive health program. CMS and Florida officials met this week to address concerns about a five-county managed care pilot program that Florida is seeking to expand statewide.

23 Aug 2011

Research into TB medication may shorten treatment regimen

Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, "has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms," VOA News reports.

23 Aug 2011

Hospital roundup: Catholic facilities losing nuns' leadership; Georgia infection rates; new VA system for Louisiana

In 1968, nuns or priests served as chief executives of 770 of the country's 796 Catholic hospitals, according to the Catholic Health Association. Today, they preside over 8 of 636 hospitals. ... The leadership shift has stirred angst in many Catholic hospitals about whether the values imparted by the nuns, concerning the treatment of both patients and employees, can withstand bottom-line forces without their day-to-day vigilance.

22 Aug 2011

Prior parasitic worm infections may complicate TB therapy

Tuberculosis (TB) is a major threat to global health, taking the lives of more than a million people worldwide each year. Its greatest impact is often in the most impoverished places on earth, where patients frequently suffer from multiple chronic illnesses at the same time. In such situations, the question of whether each individual illness might make concurrent illnesses more difficult to treat becomes a critical issue both for specific patients and for general public health.

19 Aug 2011

MSF warns global shortage of drug-resistant TB treatment likely

As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, "enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns," according to PlusNews.

18 Aug 2011

Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China

Bayer Healthcare announced on Monday it "has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO," according to a Bayer press release.

17 Aug 2011

Methodist, Philips partner to develop new imaging technology for infectious diseases

The Methodist Hospital Research Institute and Philips Healthcare are collaborating to develop new imaging technology that could be used to help identify the start -- and cause -- of an infectious disease epidemic.

From Philips Healthcare 17 Aug 2011

Inexpensive microcalorimeters can quickly detect TB

Researchers have discovered a faster, cheaper method for the diagnosis of tuberculosis (TB). A major barrier in TB prevention, especially in developing countries, is that diagnosis is slow and costly.

17 Aug 2011

Bird malaria in Britain worries experts

British birds are being increasingly detected with malaria. Two decades back few British species showed regular signs of infection but now some 30 types are infected, monitoring projects have found. The problem is linked to a rapid growth in mosquito populations, which is attributed to a rise of about 1 degrees centigrade in global average temperature, say experts.

15 Aug 2011

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

12 Aug 2011

Alternatives needed to inaccurate blood tests used to diagnose active TB

A guest post in PLoS Medicine's "Speaking of Medicine" blog, written by tuberculosis (TB) researchers Madhukar Pai of McGill University, David Dowdy of the Johns Hopkins Bloomberg School of Public Health, and Karen Steingart of the University of Washington School of Public Health, examines the medical, public health and economic consequences of the widespread use of inaccurate antibody-based serological diagnostic tests for active TB.

12 Aug 2011

Researchers discover key reason why pyrazinamide shortens duration of TB therapy

Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood.

12 Aug 2011

Researchers identify unknown link between migration of WBCs to infected tissues, immune memory

Researchers from Dr. Woodland's lab at the Trudeau Institute have now identified a previously unknown link between the migration of white blood cells to infected tissues and the ability of these cells to survive and become long-lived memory cells after the infection has been cleared.

11 Aug 2011

BCG vaccine can help immune system recognise cancer cells as 'foreign'

Scientists have found a potential new mechanism to stimulate the body's own ability to fight cancer using Baculillus Calmette-Guerin (BCG) - the germ commonly used to inoculate against tuberculosis.

11 Aug 2011

Commercial blood serum antibody tests cost-effective, not accurate for active TB

Commercial blood serum antibody tests—widely used in India and other developing countries to diagnose active tuberculosis—are not accurate or cost-effective, according to an analysis by researchers at the Johns Hopkins Bloomberg School of Public Health, the University of Washington School of Public Health and McGill University.

11 Aug 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

TB urine test developed by Indian researchers offers quicker, less invasive diagnosis

Global Fund to resume suspended grants to China

A pain-free way of tackling dental decay

Research may help explain why live attenuated influenza vaccine elicits protection

Fla., CMS discuss Medicaid managed care options; Calif. may shrink healthy families enrollment

Research into TB medication may shorten treatment regimen

Hospital roundup: Catholic facilities losing nuns' leadership; Georgia infection rates; new VA system for Louisiana

Prior parasitic worm infections may complicate TB therapy

MSF warns global shortage of drug-resistant TB treatment likely

Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China

Methodist, Philips partner to develop new imaging technology for infectious diseases

Inexpensive microcalorimeters can quickly detect TB

Bird malaria in Britain worries experts

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Alternatives needed to inaccurate blood tests used to diagnose active TB

Researchers discover key reason why pyrazinamide shortens duration of TB therapy

Researchers identify unknown link between migration of WBCs to infected tissues, immune memory

BCG vaccine can help immune system recognise cancer cells as 'foreign'

Commercial blood serum antibody tests cost-effective, not accurate for active TB

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in